[
    [
        {
            "time": "2023-10-01",
            "original_text": "SPDR S&P Dividend ETF Experiences Big Outflow",
            "features": {
                "keywords": [
                    "SPDR",
                    "S&P",
                    "Dividend",
                    "ETF",
                    "Big",
                    "Outflow"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "SPDR S&P Dividend ETF Experiences Big Outflow",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Drugmakers’ lobbying spending at 10-year high as Washington targets soaring prices",
            "features": {
                "keywords": [
                    "Drugmakers'",
                    "lobbying",
                    "spending",
                    "10-year",
                    "high",
                    "Washington",
                    "targets",
                    "soaring",
                    "prices"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Drugmakers’ lobbying spending at 10-year high as Washington targets soaring prices",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "AbbVie's Brain Cancer Candidate Fails in Phase III Study",
            "features": {
                "keywords": [
                    "AbbVie's",
                    "Brain",
                    "Cancer",
                    "Candidate",
                    "Fails",
                    "Phase",
                    "III",
                    "Study"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie's Brain Cancer Candidate Fails in Phase III Study",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]